Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study
Crossref DOI link: https://doi.org/10.1007/s00415-014-7363-2
Published Online: 2014-05-03
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jongen, Peter Joseph
,
Lehnick, Dirk
Koeman, Jan
Frequin, Stephan
Heersema, Dorothea
Kornips, Bert
Schyns-Soeterboek, Angelique
Visser, Leo H.
Schiphof, Paul
Valkenburg, Anton
Hiel, Johan
License valid from 2014-05-03